Bristol-Myers Squibb Co.
Market Cap
110B
Short interest (May 15)
1.8%
Net Short (Jun 03 ): 0.0%
Borrow Fee
0.94%
↑ 42.0%
Available Shares
10M
↓ 0.0%
Price Chart
Company Overview
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.